promising therapeutic targets in mpns
Published 2 months ago • 141 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
0:59
investigating jak2v617f as a therapeutic target in mpns
-
1:49
advances in the science and treatment of mpns
-
5:42
promising therapeutic efficacy of ebv-specific t-cell immunotherapy tabelecleucel in ptld
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:30
advancements in prognostication tools in mpns in recent years
-
45:36
panel discussion | marketing 2.0 conference
-
3:35
epigenomics in precision oncology
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:14
promising novel agents in aml: menin inhibitors
-
1:40
new therapeutic approaches targeting xpo1-overexpression in tp53-mutated myeloid malignancies
-
1:47
shared treatment decision-making
-
1:53
preclinical research for the future of cellular therapies
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
0:57
novel therapeutic strategies in all
-
1:19
the promise of precision medicine in mds
-
3:36
the future of cancer medicine and the potential for personalized precision medicine using ai tools
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment